SILVER-ENHANCED IN SITU HYBRIDIZATION AS AN ALTERNATIVE TO FLUORESCENCE IN SITU HYBRIDIZATION FOR ASSAYING HER2 AMPLIFICATION IN CLINICAL BREAST CANCER

被引：0
作者：
Han, S. [1 ]
Kim, J. S. [2 ]
Gwak, G. [1 ]
Park, K.
机构：
[1] Inje Univ, Sanggye Paik Hosp, Breast Canc Ctr, Seoul, South Korea
[2] St Mary Hosp Uijungbu, Uijungbu, South Korea
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
50P
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [41] Evaluation of HER2 Gene Amplification in Breast Cancer Using Nuclei Microarray in Situ Hybridization
    Jiang, Huiyong
    Bai, Xiaoyan
    Zhang, Cheng
    Zhang, Xuefeng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (05) : 5519 - 5527
  • [42] Dual-colour chromogenic in-situ hybridization is a potential alternative to fluorescence in-situ hybridization in HER2 testing
    Hwang, Cheng-Cheng
    Pintye, Mariann
    Chang, Liang-Che
    Chen, Huang-Yang
    Yeh, Kun-Yan
    Chein, Hui-Ping
    Lee, Nin
    Chen, Jim-Ray
    HISTOPATHOLOGY, 2011, 59 (05) : 984 - 992
  • [43] In situ analysis of HER2 mRNA in gastric carcinoma: comparison with fluorescence in situ hybridization, dual-color silver in situ hybridization, and immunohistochemistry
    Kim, Min A.
    Jung, Jung Eun
    Lee, Hee Eun
    Yang, Han-Kwang
    Kim, Woo Ho
    HUMAN PATHOLOGY, 2013, 44 (04) : 487 - 494
  • [44] Double staining chromogenic in situ hybridization is a useful alternative to fluorescent in situ hybridization: first comparative study of HER2 and TOP2A gene amplification in breast cancer
    Lacroix-Triki, M.
    Mounie, E.
    Charafe-Jauffret, E.
    Jacquemier, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S85 - S86
  • [45] Determination of the Her-2/neu Gene Amplification Status in Cytologic Breast Cancer Specimens Using Automated Silver-enhanced In-situ Hybridization (SISH)
    Fritzsche, Florian Rudolf
    Bode, Peter K.
    Moch, Holger
    Kristiansen, Glen
    Varga, Zsuzsanna
    Bode, Beata
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (08) : 1180 - 1185
  • [46] Comparison between Fluorescence In Situ Hybridization (FISH) and Dual In Situ Hybridization (DISH) in the determination of HER2 status in breast cancer among Filipinos
    Espiritu, G. A.
    dela Fuente, E.
    Diwa, M.
    VIRCHOWS ARCHIV, 2019, 475 : S98 - S98
  • [47] Correlation of Her2/Neu testing using chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) in breast cancer
    Hanna, WM
    Kwok, K
    LABORATORY INVESTIGATION, 2005, 85 : 35A - 35A
  • [48] Correlation of Her2/neu testing using chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) in breast cancer
    Hanna, WM
    Kwok, K
    MODERN PATHOLOGY, 2005, 18 : 35A - 35A
  • [49] HER2 Testing for Breast Cancer in the Genomics Laboratory A Sea Change for Fluorescence In Situ Hybridization
    Geiersbach, Katherine B.
    Sill, Daniel R.
    Meyer, Reid G.
    Yuhas, Jason A.
    Sukov, William R.
    Mounajjed, Taofic
    Carter, Jodi M.
    Jenkins, Robert B.
    Chen, Beiyun
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (07) : 883 - 886
  • [50] HER2 positivity in breast carcinoma: A comparison of chromogenic in situ hybridization with fluorescence in situ hybridization in tissue microarrays, with targeted evaluation of intratumoral heterogeneity by in situ hybridization
    Loring, P
    Cummins, R
    O'Grady, A
    Kay, EW
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2005, 13 (02) : 194 - 200
12345